Home

Insights

PE

Krebs Biochemicals & Industries Ltd P/E Ratio

Krebs Biochemicals & Industries Ltd P/E Ratio

download
stocks purchased

₹ 0.1 Cr

Volume transacted

stocks purchased

8.7 K

stocks traded

Last Updated time: 14 Jul 13:55 PM

Image

Krebs Biochemicals & Industries Ltd

NSE: KREBSBIO

PE

0

Last updated : 14 Jul 13:55 PM

Key Highlights

    The P/E Ratio of Krebs Biochemicals & Industries Ltd is 0 as of 14 Jul 13:55 PM .a1#The P/E Ratio of Krebs Biochemicals & Industries Ltd changed from 0 on March 2019 to 0 on March 2023 . This represents a CAGR of 0.0% over 5 years. a1#The Latest Trading Price of Krebs Biochemicals & Industries Ltd is ₹ 82.87 as of 12 Jul 15:30 .a1#The PE Ratio of Pharmaceuticals Industry has changed from 28.5 to 27.2 in 5 years. This represents a CAGR of -0.93%a1# The PE Ratio of Automobile industry is 17.2. The PE Ratio of Finance industry is 24.7. The PE Ratio of IT - Software industry is 29.2. The PE Ratio of Pharmaceuticals industry is 35.8. The PE Ratio of Retail industry is 143.1. The PE Ratio of Textiles industry is 12.1. In 2024a1#The Market Cap of Krebs Biochemicals & Industries Ltd changed from ₹ 192.91 crore on March 2019 to ₹ 121.6 crore on March 2023 . This represents a CAGR of -8.82% over 5 years. a1#The Revenue of Krebs Biochemicals & Industries Ltd changed from ₹ 10.77 crore to ₹ 12.18 crore over 8 quarters. This represents a CAGR of 6.34% a1#The EBITDA of Krebs Biochemicals & Industries Ltd changed from ₹ -6.14 crore to ₹ -2.9 crore over 8 quarters. This represents a CAGR of -31.27% a1#The Net Pr of Krebs Biochemicals & Industries Ltd changed from ₹ -8.14 crore to ₹ -5.85 crore over 8 quarters. This represents a CAGR of -15.23% a1#The Dividend Payout of Krebs Biochemicals & Industries Ltd changed from 0 % on March 2019 to 0 % on March 2023 . This represents a CAGR of 0.0% over 5 years. a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

×

Historical P/E Ratio of Krebs Biochemicals & Industries Ltd

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Historical P/E Ratio of Krebs Biochemicals & Industries Ltd

Period
Mar '190
Mar '200
Mar '210
Mar '220
Mar '230

Company Fundamentals for Krebs Biochemicals & Industries Ltd

Market Cap

178 Cr

EPS

0.0

P/E Ratio (TTM) *

0.0

P/B Ratio (TTM) *

0.0

Day’s High

85.9

Day’s Low

81.0

DTE *

-1.6

ROE *

16.5

52 Week High

93.9

52 Week Low

60.0

ROCE *

-12.0

* All values are consolidated

Last Updated time: 14 Jul 13:55 PM

* All values are consolidated

Last Updated time: 14 Jul 13:55 PM

Image

Krebs Biochemicals & Industries Ltd

NSE: KREBSBIO

PRICE

82.87

0.26 (0.31%)

stock direction

Last updated : 12 Jul 15:30

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

SWOT Analysis Of Krebs Biochemicals & Industries Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

Asset Value vs Market Value of Krebs Biochemicals & Industries Ltd

Market Value

179

Asset Value

16

10.1 X

Value addition

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Krebs Biochemicals & Industries Ltd0178
Sun Pharmaceuticals Industries Ltd37378,675
Cipla Ltd28122,093
Divis Laboratories Ltd75120,480
Zydus Lifesciences Ltd30118,217
Dr Reddys Laboratories Ltd20112,137

Key Valuation Metric of Krebs Biochemicals & Industries Ltd

Earnings

-19 Cr

0.0 X

PE Ratio

Market Cap

₹178.67Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Earnings

-19 Cr

0.0 X

PE Ratio

Market Cap

₹178.67Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

×

Historical Market Cap of Krebs Biochemicals & Industries Ltd

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Historical Market Cap of Krebs Biochemicals & Industries Ltd

Period
Mar '19193
Mar '20147
Mar '21174
Mar '22309
Mar '23122

* All values are a in crore

×

Historical Revenue of Krebs Biochemicals & Industries Ltd

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Historical Revenue of Krebs Biochemicals & Industries Ltd

Period
Jun '2211
Sep '2221
Dec '229
Mar '2312
Jun '2311
Sep '2315
Dec '2313
Mar '2412

* All values are a in crore

×

Historical EBITDA of Krebs Biochemicals & Industries Ltd

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

Historical EBITDA of Krebs Biochemicals & Industries Ltd

Period
Jun '22-6
Sep '22-2
Dec '22-3
Mar '23-4
Jun '23-3
Sep '23-1
Dec '23-2
Mar '24-3

* All values are a in crore

×

Historical Net Profit of Krebs Biochemicals & Industries Ltd

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Historical Net Profit of Krebs Biochemicals & Industries Ltd

Period
Jun '22-8
Sep '22-4
Dec '22-6
Mar '23-7
Jun '23-5
Sep '23-4
Dec '23-5
Mar '24-6

* All values are a in crore

×

Historical Dividend Payout of Krebs Biochemicals & Industries Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of Krebs Biochemicals & Industries Ltd

Period
Mar '190
Mar '200
Mar '210
Mar '220
Mar '230

* All values are a in %

About Krebs Biochemicals & Industries Ltd

About Krebs Biochemicals & Industries Ltd

    Krebs Biochemicals & Industries Ltd (Formerly Krebs Biochemicals Ltd), promoted by R T Ravi in 1991 is engaged in the manufacture of Active Pharmaceutical Ingredients(API) through Fermentation process, one among very few in the world to do the same. Krebs develops commercially viable biotech processes for application in medicine, agriculture and industry. Undertaking contract manufacturing for large pharmaceutical and multinational companies and developing products for sale in global markets, the Company possesses expertise and infrastructure in chemical synthesis, fermentation and enzymatic technologies. KBIL which commenced commercial operations in the year 1994 with an installed capacity of 60 TPA has now grown to 150 TPA. KBL went to public with an IPO in 1994. During 2001-02, the company launched Vitamin C(I P Grade) through Fermentation Process. The Company commissioned 2.5 MW Co-generation Power Plant at Unit II in Vizag during 2003-04 and started operations on it from July, 2004 onwards.

Krebs Biochemicals & Industries Ltd News Hub

News

Krebs Biochemicals & Industries Ltd leads gainers in 'B' group

Shreyans Industries Ltd, Alphageo (India) Ltd, Coral India Finance & Housing Ltd and IVP L...

Read more

08 Jul 202412:16

News

Krebs Biochemicals & Industries announces board meeting date

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Compa...

Read more

08 May 202412:55

News

Krebs Biochemicals & Industries to hold board meeting

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Compa...

Read more

19 Jan 202417:16

News

Krebs Biochemicals & Industries to convene board meeting

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Compa...

Read more

19 Oct 202311:05

News

Krebs Biochemicals & Industries to conduct AGM

Krebs Biochemicals & Industries announced that the 31th Annual General Meeting (AGM) of th...

Read more

12 Aug 202317:55

News

Krebs Biochemicals & Industries to conduct board meeting

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Compa...

Read more

22 Jul 202312:37

Product Composition by Percentage (Revenue)

FAQs for PE of Krebs Biochemicals & Industries Ltd

What is Krebs Biochemicals & Industries Ltd current share price?

The current market price of Krebs Biochemicals & Industries Ltd as of July 14, 2024 is ₹82.87.

What is Krebs Biochemicals & Industries Ltd's market cap?

Krebs Biochemicals & Industries Ltd's market capitalisation stood at ₹178 Cr as of July 14, 2024

What are Krebs Biochemicals & Industries Ltd's total net assets?

According to Krebs Biochemicals & Industries Ltd's most recent financial filings, the company's net assets total ₹16.1 Cr.

Is Krebs Biochemicals & Industries Ltd making a profit or loss?

Krebs Biochemicals & Industries Ltd's net Profit as of July 14, 2024 is close to ₹-19 Cr.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199